Immunometabolic Reprogramming as a Therapeutic Platform: Integrating Systems Immunology with Precision Biopharmaceutical Engineering

Hosein Yousefi, Cobra Moradian

Open source

DOI
10.1080/08820139.2026.2731116
Published
2026-09-11
Container
Immunological Investigations
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/08820139.2026.2731116,
  title = {Immunometabolic Reprogramming as a Therapeutic Platform: Integrating Systems Immunology with Precision Biopharmaceutical Engineering},
  author = {Hosein Yousefi and Cobra Moradian},
  year = {2026},
  journal = {Immunological Investigations},
  doi = {10.1080/08820139.2026.2731116},
  url = {https://doi.org/10.1080/08820139.2026.2731116}
}

RIS

TY  - JOUR
TI  - Immunometabolic Reprogramming as a Therapeutic Platform: Integrating Systems Immunology with Precision Biopharmaceutical Engineering
AU  - Hosein Yousefi
AU  - Cobra Moradian
PY  - 2026
JO  - Immunological Investigations
DO  - 10.1080/08820139.2026.2731116
UR  - https://doi.org/10.1080/08820139.2026.2731116
ER  - 

APA

Yousefi, H., & Moradian, C. (2026). Immunometabolic Reprogramming as a Therapeutic Platform: Integrating Systems Immunology with Precision Biopharmaceutical Engineering. Immunological Investigations. https://doi.org/10.1080/08820139.2026.2731116

Source records